Edition:
United States

Clementia Pharmaceuticals Inc (CMTA.OQ)

CMTA.OQ on NASDAQ Stock Exchange Global Select Market

9.76USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$9.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,632
52-wk High
$20.12
52-wk Low
$8.23

Chart for

About

Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and... (more)

Overall

Beta: --
Market Cap(Mil.): $309.56
Shares Outstanding(Mil.): 31.72
Dividend: --
Yield (%): --

Financials

  CMTA.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -2.88 -- --
ROI: -97.33 2.89 12.63
ROE: -- 1.65 14.82

BRIEF-Clementia Pharmaceuticals Inc Q4 2017 Loss Per Share $0.37

* Q4 EARNINGS PER SHARE VIEW $-0.35 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

Feb 28 2018

Earnings vs. Estimates